Dr Dominique Bettex, responsible for cardiac anaesthesia and intensive care at University Hospital Zurich in Switzerland, describes how the mechanisms of action of levosimendan relate to its effects in clinical cases and the literature. Presented as part of the ‘ClinicalXChange’ sessions held on the Orion Pharma booth at the 37th ISICEM meeting, Brussels, 2017.
Dr Alexandre Mebazaa shares data from recent publications exploring the multiple effects of levosimendan.
Dr Alexandre Mebazaa discusses the inotropic and decongestive effects of levosimendan in heart failure and cardiogenic shock, in the light of recent studies.
Alternatively login via
Back to epgonline.org